203 related articles for article (PubMed ID: 22162481)
1. Three-year efficacy and safety of LB03002, a once-weekly sustained-release growth hormone (GH) preparation, in prepubertal children with GH deficiency (GHD).
Péter F; Bidlingmaier M; Savoy C; Ji HJ; Saenger PH
J Clin Endocrinol Metab; 2012 Feb; 97(2):400-7. PubMed ID: 22162481
[TBL] [Abstract][Full Text] [Related]
2. 24-month use of once-weekly GH, LB03002, in prepubertal children with GH deficiency.
Khadilkar V; Radjuk KA; Bolshova E; Khadgawat R; El Kholy M; Desai M; Peterkova V; Mericq V; Kratzsch J; Siepl EC; Martin D; Lopez P; Ji HJ; Bae YJ; Lee JH; Saenger PH
J Clin Endocrinol Metab; 2014 Jan; 99(1):126-32. PubMed ID: 24170106
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency.
Hwang JS; Lee HS; Chung WY; Han HS; Jin DK; Kim HS; Ko CW; Lee BC; Lee DY; Lee KH; Shin JH; Suh BK; Yoo HW; Ji HJ; Lee JH; Bae YJ; Kim DH; Yang SW
Eur J Endocrinol; 2013 Aug; 169(2):179-85. PubMed ID: 23682096
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency.
Peter F; Savoy C; Ji HJ; Juhasz M; Bidlingmaier M; Saenger P
Eur J Endocrinol; 2009 Mar; 160(3):349-55. PubMed ID: 19074465
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics and pharmacodynamics of a new sustained-release growth hormone (GH), LB03002, versus daily GH in adults with GH deficiency.
Bidlingmaier M; Kim J; Savoy C; Kim MJ; Ebrecht N; de la Motte S; Strasburger CJ
J Clin Endocrinol Metab; 2006 Aug; 91(8):2926-30. PubMed ID: 16720652
[TBL] [Abstract][Full Text] [Related]
6. Effects of once-weekly sustained-release growth hormone: a double-blind, placebo-controlled study in adult growth hormone deficiency.
Biller BM; Ji HJ; Ahn H; Savoy C; Siepl EC; Popovic V; Coculescu M; Roemmler J; Gavrila C; Cook DM; Strasburger CJ
J Clin Endocrinol Metab; 2011 Jun; 96(6):1718-26. PubMed ID: 21411551
[TBL] [Abstract][Full Text] [Related]
7. Once-Weekly Administration of Sustained-Release Growth Hormone in Korean Prepubertal Children with Idiopathic Short Stature: A Randomized, Controlled Phase II Study.
Hwang JS; Lee HS; Lee KH; Yoo HW; Lee DY; Suh BK; Ko CW; Chung WY; Jin DK; Shin CH; Han HS; Han S; Kim HS
Horm Res Paediatr; 2018; 90(1):54-63. PubMed ID: 29925064
[TBL] [Abstract][Full Text] [Related]
8. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency.
Moore WV; Nguyen HJ; Kletter GB; Miller BS; Rogers D; Ng D; Moore JA; Humphriss E; Cleland JL; Bright GM
J Clin Endocrinol Metab; 2016 Mar; 101(3):1091-7. PubMed ID: 26672637
[TBL] [Abstract][Full Text] [Related]
10. 12-month effects of once-weekly sustained-release growth hormone treatment in adults with GH deficiency.
Biller BM; Ji HJ; Ahn H; Savoy C; Siepl EC; Popovic V; Coculescu M; Roemmler J; Gavrila C; Cook DM; Strasburger CJ
Pituitary; 2013 Sep; 16(3):311-8. PubMed ID: 22915288
[TBL] [Abstract][Full Text] [Related]
11. Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiency.
Roemmler J; Gockel A; Otto B; Bidlingmaier M; Schopohl J
Clin Endocrinol (Oxf); 2012 Jan; 76(1):88-95. PubMed ID: 21682757
[TBL] [Abstract][Full Text] [Related]
12. Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens.
Albertsson Wikland K; Alm F; Aronsson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson S; Kriström B; Marcus C; Moëll C; Nilsson KO; Ritzén M; Tuvemo T; Westgren U; Westphal O; Aman J
Acta Paediatr Suppl; 1999 Feb; 88(428):80-4. PubMed ID: 10102059
[TBL] [Abstract][Full Text] [Related]
13. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
Romer T; Saenger P; Peter F; Walczak M; Le Bouc Y; Khan-Boluki J; Berghout A
Horm Res; 2009; 72(6):359-69. PubMed ID: 19844125
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K
J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519
[TBL] [Abstract][Full Text] [Related]
15. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency.
Peterkova V; Arslanoglu I; Bolshova-Zubkovskaya E; Romer T; Zdravkovic D; Kratzsch J; Ji HJ; Savoy C; Saenger P
Horm Res; 2007; 68(6):288-93. PubMed ID: 17627092
[TBL] [Abstract][Full Text] [Related]
17. Once-Weekly Somapacitan vs Daily GH in Children With GH Deficiency: Results From a Randomized Phase 2 Trial.
Sävendahl L; Battelino T; Brod M; Højby Rasmussen M; Horikawa R; Juul RV; Saenger P;
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1847-61. PubMed ID: 31917835
[TBL] [Abstract][Full Text] [Related]
18. A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency.
Reiter EO; Attie KM; Moshang T; Silverman BL; Kemp SF; Neuwirth RB; Ford KM; Saenger P;
J Clin Endocrinol Metab; 2001 Oct; 86(10):4700-6. PubMed ID: 11600528
[TBL] [Abstract][Full Text] [Related]
19. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
Lampit M; Hochberg Z
J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
[TBL] [Abstract][Full Text] [Related]
20. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
